CAR-T Meeting 2021 | The progression of research into CAR T-cell therapy
Hisse M. van Santen
• 8 Feb 2021
Hisse M. van Santen, PhD, Centro Biologia Molecular Severo Ochoa, Madrid, Spain, shares his highlights from the 3rd European CAR T-cell meeting and discusses how research into CAR-T cell therapy has changed and which aspects of CAR-T cell therapy are currently being focused on. This interview took place during the 3rd European CAR T-cell Meeting.
